Florida cancer patients get AI-Powered personalized treatment plans in new study
NCT ID NCT07167381
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing whether a new tool called xDRIVE, which combines artificial intelligence and tumor profiling, can quickly suggest personalized treatment options for cancer patients in Florida whose cancer has come back or not responded to standard treatments. The goal is to see if the tool can return useful recommendations within two weeks for at least 72% of the 210 participants, including children and underserved communities. If it works, this approach could help doctors make more informed treatment decisions for hard-to-treat cancers.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
xDRIVE tumor profiling (diagnostic test using AI and drug sensitivity testing)
What this could lead to
If successful, this could show that AI-driven personalized treatment recommendations are feasible and help doctors choose better therapies for hard-to-treat cancers.
What could go wrong
This is an early feasibility study, not a treatment trial. It may not improve outcomes for all patients, and results depend on timely data return and physician use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
First Ascent Biomedical
RECRUITINGMiami, Florida, 33183, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Florida International University
ACTIVE_NOT_RECRUITINGMiami, Florida, 33199, United States